132 related articles for article (PubMed ID: 7393988)
1. Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carboxyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets.
Galli C; Agradi E; Petroni A; Socini A
Pharmacol Res Commun; 1980 Apr; 12(4):329-37. PubMed ID: 7393988
[No Abstract] [Full Text] [Related]
2. Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man.
Luzzatto G; Fabris F; Dal Bo Zanon R; Girolami A
Arzneimittelforschung; 1986 Jun; 36(6):972-3. PubMed ID: 2943294
[TBL] [Abstract][Full Text] [Related]
3. AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonyl-meth oxy coumarin) inhibits the release of arachidonic acid in human platelets stimulated by thrombin.
Porcellati S; Costantini V; Prosdocimi M; Pistolesi R; Porrovecchio P; Nenci GG; Goracci G
Thromb Res; 1987 Jul; 47(1):15-24. PubMed ID: 3116710
[TBL] [Abstract][Full Text] [Related]
4. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmet hox y coumarin) on human platelets in vitro.
Prosdocimi M; Zatta A; Gorio A; Zanetti A; Dejana E
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):305-10. PubMed ID: 3012375
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonyl methoxy coumarin) of platelet aggregation in dog stenosed coronary artery.
Prosdocimi M; Finesso M; Tessari F; Gorio A; Languino LR; de Gaetano G; Dejana E
Thromb Res; 1985 Aug; 39(4):399-409. PubMed ID: 3840290
[TBL] [Abstract][Full Text] [Related]
6. Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1 alpha production in perfused aortas, in experimentally hypercholesterolaemic rabbits.
Socini A; Petroni A; Colli S; Colombo C; Galli C
Pharmacol Res Commun; 1982 Mar; 14(3):189-97. PubMed ID: 7048340
[No Abstract] [Full Text] [Related]
7. The effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxy- carbonylmethoxycoumarin) on washed human platelet aggregation induced by platelet activating factor (PAF) and epinephrine.
Zanetti A; Zatta A; Prosdocimi M; Dejana E
Eur J Pharmacol; 1986 Aug; 128(1-2):119-27. PubMed ID: 2944757
[TBL] [Abstract][Full Text] [Related]
8. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
[No Abstract] [Full Text] [Related]
9. Influence of some beta blockers (pindolol, atenolol, timolol and metoprolol) on aggregation and arachidonic acid metabolism in human platelets.
Srivastava KC
Prostaglandins Leukot Med; 1987 Sep; 29(1):79-84. PubMed ID: 2890173
[TBL] [Abstract][Full Text] [Related]
10. Influence of strontium chloride on blood platelet function.
Togna G; Gallozzi S; Caprino L
Arch Toxicol Suppl; 1989; 13():366-9. PubMed ID: 2505737
[No Abstract] [Full Text] [Related]
11. Lithium stimulates thromboxane B2 formation in human platelets.
Imandt L; Tijhuis D; Wessels H; Haanen C; van den Berg R; Thomas C
Prostaglandins Med; 1981 Nov; 7(5):421-9. PubMed ID: 6798588
[TBL] [Abstract][Full Text] [Related]
12. Carbocromen inhibits arachidonic acid-induced platelet aggregation and TXA2 formation.
Heinroth I; Förster W
Prostaglandins Leukot Med; 1984 Apr; 14(1):13-4. PubMed ID: 6427789
[No Abstract] [Full Text] [Related]
13. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
[No Abstract] [Full Text] [Related]
14. Effect of AD6 (8-monochloro-3-beta-diethylamino-ethyl-4-methyl-7-ethoxycarbonylme tho xy coumarin) on cyclic nucleotide phosphodiesterases in human platelets.
Hakim G; Fiorentini D; Falasca A; Prosdocimi M; Rossi CA
Experientia; 1988 Mar; 44(3):226-8. PubMed ID: 2832208
[TBL] [Abstract][Full Text] [Related]
15. Role of thromboxane A2.
Ambler J; Birch J; Maguire ED; Wallis RB
Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
[No Abstract] [Full Text] [Related]
16. Coffee extracts inhibit platelet aggregation in vivo and in vitro.
Bydlowski SP; Yunker RL; Rymaszewski Z; Subbiah MT
Int J Vitam Nutr Res; 1987; 57(2):217-23. PubMed ID: 3115908
[TBL] [Abstract][Full Text] [Related]
17. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation.
Agradi E; Petroni A; Socini A; Galli C
Prostaglandins; 1981 Aug; 22(2):255-66. PubMed ID: 6794104
[TBL] [Abstract][Full Text] [Related]
18. The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin.
Porcellati S; Costantini V; Prosdocimi M; Stasi M; Pistolesi R; Nenci GG; Goracci G
Agents Actions; 1990 Mar; 29(3-4):364-73. PubMed ID: 2111085
[TBL] [Abstract][Full Text] [Related]
19. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Ostermann G; Block HU; Till U
Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of platelet aggregation and reduced formation of thromboxane and lipoxygenase products in platelets by oil of cloves.
Srivastava KC; Justesen U
Prostaglandins Leukot Med; 1987 Sep; 29(1):11-8. PubMed ID: 3118394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
